AACR20: key data presented at the ‘COVID-19 and Cancer’ plenary session

Written by Rachel Jenkins, Future Science Group

Since the global emergence of COVID-19, an important question has been what impact the virus will have on the most vulnerable populations, including cancer patients. A late addition to the American Association for Cancer Research (AACR) Virtual Annual Meeting I (27–28 April 2020) is the timely ‘COVID-19 and Cancer’ plenary session. In this article, we round-up key data presented during the session. The experience of treating patients with cancer during the COVID-19 pandemic in China Zhang L et al., 2020 In January – February, researchers from three Chinese institutions analyzed data taken from 28 COVID-19-positive cancer patients. A total of...

To view this content, please register now for access

It's completely free